← All organizations
Asian Institute of Gastroenterology
Academic/HospitalWebsite ↗
Also known as: AIG Hospitals | Asian Institue of Gastroenterology | Asian Institute of Gastroenterolgy India | Asian Institute of Gastroenterology | ASIAN INSTITUTE OF GASTROENTEROLOGY/AIG HOSPITALS | Asian Institute of Gastroenterology hospitals | Asian Institute of Gastroenterology, Hyderabad, India | Asian Institute of Gastroenterology, India | Asian lnstitute of Gastroenterology
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2009Last known activity
Jan 1, 2026
Timeline
1990s
- Jan 1, 1994
Asian Institute of Gastroenterology— Founded
Drugs by trial phase (41 distinct, 24 trials)
Phase 4 (17 own, 0 via acquisition)
- bone marrow derived mesenchymal stem cells
- bone marrow derived autologous cd34+ selected cells
- amoxicillin
- semaglutide
- vonoprazan
- bifidobacterium infantis
- bifidobacterium breve
- bifidobacterium longum
- lactobacillus plantarum
- vsl #3
- streptococcus salivarius
- clarithromycin
- amikacin
- esomeprazole
- Lactobacillus acidophilus
- +2 more
Phase 3 (12 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (50)
- NCT07297069Lead sponsorPhase 2Jan 1, 2026
- NCT07297069Sponsor investigatorPhase 2Jan 1, 2026
- NCT06953986Sponsor investigatorN/AJun 7, 2025
- NCT06953986OfficialN/AJun 7, 2025
- NCT06953986Lead sponsorN/AJun 7, 2025
- NCT06955520Sponsor investigatorN/AApr 30, 2025
- NCT06955520OfficialN/AApr 30, 2025
- NCT06955520Lead sponsorN/AApr 30, 2025
- NCT06919458Lead sponsorPhase 3Apr 7, 2025
- NCT06919458Sponsor investigatorPhase 3Apr 7, 2025
- NCT06959368Lead sponsorPhase 4Mar 25, 2025
- NCT06808074Lead sponsorPhase 4Feb 12, 2025
- NCT06808074Sponsor investigatorPhase 4Feb 12, 2025
- NCT06581783OfficialN/ANov 1, 2024
- NCT06581783Lead sponsorN/ANov 1, 2024
Details
- Founded
- Hyderabad, IN Jan 1, 1994
- Last known activity
- Jan 1, 2026